Perfluoroalkyl substances exposure and thyroid hormones in humans: epidemiological observations and implications
- PMID: 28443254
- PMCID: PMC5401824
- DOI: 10.6065/apem.2017.22.1.6
Perfluoroalkyl substances exposure and thyroid hormones in humans: epidemiological observations and implications
Abstract
Thyroid hormones play crucial roles in normal neurodevelopment of fetus and child. Many chemicals can affect control and homeostasis of thyroid hormones, and eventually lead to various adverse health effects including neurodevelopmental disorders. Perfluoroalkyl substances (PFASs) are among the thyroid disrupting chemicals that can be encountered among general human population. Due to their unique physicochemical characteristics, PFASs have been used as surfactants and surface coating materials in many applications. Therefore, PFASs have been frequently detected in humans and environment worldwide. In cross-sectional studies using nationally representative general human populations of United States, several PFASs have shown significant associations with thyroid hormones. Moreover, among pregnant women and their infants, not only major PFASs such as perfluorooctane sulfonic acid and perfluorooctanoic acid, but also those with shorter or longer carbon chains showed significant associations with thyroid hormones. Often demographic characteristics such as sex, age, and disease status appear to influence the associations between PFASs exposure and thyroid hormones. In general, major PFASs showed hypothyroidism effects among pregnant women and infants. As 8 carbon based PFASs have been phased out, those with shorter or longer carbon chains have been used in growing amount as replacement. However, only limited information is available for their occurrences and toxicity among humans. Further investigations on these substituting PFASs are required. In addition, efforts are warranted to identify sources of and mitigate exposure to these thyroid disrupting chemicals especially during pregnancy and early stages of life.
Keywords: Biomonitoring; Disruption; Perfluoroalkyl substances; Pregnant women; Thyroid; population.
Conflict of interest statement
Conflict of interest: No potential conflict of interest relevant to this article was reported.
Figures
References
-
- Christensen DL, Baio J, Van Naarden Braun K, Bilder D, Charles J, Constantino JN, et al. Prevalence and characteristics of autism spectrum disorder among children aged 8 years: autism and developmental disabilities monitoring network, 11 sites, United States, 2012. MMWR Surveill Summ. 2016;65:1–23. - PMC - PubMed
-
- Weintraub K. The prevalence puzzle: Autism counts. Nature. 2011;479:22–24. - PubMed
-
- Bergman A, Heindel JJ, Jobling S, Kidd KA, Zoeller RT. State of the science of endocrine disrupting chemicals – 2012. Geneva: United Nations Environment Programme (UNEP) and World Health Organization (WHO); 2013.
-
- Porterfield SP, Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development: current perspectives. Endocr Rev. 1993;14:94–106. - PubMed
-
- Ballesteros V, Costa O, Iñiguez C, Fletcher T, Ballester F, Lopez-Espinosa MJ. Exposure to perfluoroalkyl substances and thyroid function in pregnant women and children: a systematic review of epidemiologic studies. Environ Int. 2017;99:15–28. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources

